Literature DB >> 16153896

BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ.

Rachel Litman1, Min Peng, Zhe Jin, Fan Zhang, Junran Zhang, Simon Powell, Paul R Andreassen, Sharon B Cantor.   

Abstract

We showed in this study that cells deficient of the BRCA1-associated BACH1 helicase, also known as BRIP1, failed to elicit homologous recombination (HR) after DNA double-stranded breaks (DSBs). BACH1-deficient cells were also sensitive to mitomycin C (MMC) and underwent MMC-induced chromosome instability. Moreover, we identified a homozygous nonsense mutation in BACH1 in a FA-J patient-derived cell line and could not detect BACH1 protein in this cell line. Expression of wild-type BACH1 in this cell line reduced the accumulation of cells at G2/M phases following exposure to DNA crosslinkers, a characteristic of Fanconi anemia (FA) cells. These results support the conclusion that BACH1 is FANCJ.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153896     DOI: 10.1016/j.ccr.2005.08.004

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  193 in total

1.  Fanconi anemia (FA) binding protein FAAP20 stabilizes FA complementation group A (FANCA) and participates in interstrand cross-link repair.

Authors:  Justin Wai Chung Leung; Yucai Wang; Ka Wing Fong; Michael Shing Yan Huen; Lei Li; Junjie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-06       Impact factor: 11.205

Review 2.  Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.

Authors:  Hyungjin Kim; Alan D D'Andrea
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

3.  Molecular basis of BACH1/FANCJ recognition by TopBP1 in DNA replication checkpoint control.

Authors:  Charles Chung Yun Leung; Zihua Gong; Junjie Chen; J N Mark Glover
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

Review 4.  Advances in the understanding of the Fanconi anemia tumor suppressor pathway.

Authors:  Anna Pickering; Jun Zhang; Jayabal Panneerselvam; Peiwen Fei
Journal:  Cancer Biol Ther       Date:  2013-09-09       Impact factor: 4.742

Review 5.  Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.

Authors:  Rohit Prakash; Yu Zhang; Weiran Feng; Maria Jasin
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-01       Impact factor: 10.005

6.  Targeting the FANCJ-BRCA1 interaction promotes a switch from recombination to poleta-dependent bypass.

Authors:  J Xie; R Litman; S Wang; M Peng; S Guillemette; T Rooney; S B Cantor
Journal:  Oncogene       Date:  2010-02-22       Impact factor: 9.867

Review 7.  Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis.

Authors:  Mary Ellen Moynahan; Maria Jasin
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03       Impact factor: 94.444

8.  Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance.

Authors:  Gary P H Ho; Steven Margossian; Toshiyasu Taniguchi; Alan D D'Andrea
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

9.  Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes.

Authors:  Roger A Greenberg; Bijan Sobhian; Shailja Pathania; Sharon B Cantor; Yoshihiro Nakatani; David M Livingston
Journal:  Genes Dev       Date:  2006-01-01       Impact factor: 11.361

10.  Redox control of the DNA damage-inducible protein DinG helicase activity via its iron-sulfur cluster.

Authors:  Binbin Ren; Xuewu Duan; Huangen Ding
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.